Reduced vascular basement-membrane immunostaining in mucinous tumours of the ovary

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 139-143

  Orre, Maxine ^a,b   Rogers, Peter A W ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; COLLAGEN TYPE 4;

ANGIOGENESIS; ARTICLE; CANCER STAGING; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; OVARY TUMOR; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; ANALYSIS OF VARIANCE; ANTIGENS, CD31; BASEMENT MEMBRANE; COLLAGEN; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MICROCIRCULATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 0031892305     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<139::AID-IJC7>3.0.CO;2-U     Document Type: Article

References (23)

1. CAMPO, E., MERINO, M.J., TAVASSOLI, F.A., CHARONIS, A.S., STETLER-STEVENSON, W.G. and LIOTTA, L.A., Evaluation of basement-membrane components and the 72-kDa type-IV collagenase in serous tumors of the ovary. Amer. J. Surg. Pathol., 16, 500-507 (1992).
2. DZIADEK, M. and MITRANGAS, K., Differences in the solubility and susceptibility to proteolytic degradation of basement-membrane components in adult and embryonic mouse tissues. Amer. J. Anat., 184, 298-310 (1989).
3. FOLKMAN, J., Tumor angiogenesis. Advanc. Cancer Res., 43, 175-203 (1985).
4. FORM, D.M., PRATT, B.M. and MADRI, J.A., Endothelial-cell proliferation during angiogenesis. In vitro modulation by basement-membrane components. Lab. Invest., 55, 521-530 (1986).
5. FURCHT, L.T., Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab. Invest., 55, 505-509 (1986).
6. GASPARINI, G., BARBARESCHI, M., BORACCHI, P., BEVILACQUA, P., VERDERIO, P., DALLA PALMA, P. and MENARD, S., 67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer. Int. J. Cancer, 60, 604-610 (1995).
7. GASPARINI, G., BONOLDI, E., VIALE, G., VERDERIO, P., BORACCHI, P., PANIZZONI, G.A., RADAELLI, U., DI BACCO, A., GUGLIELMI, R.B. and BEVILACQUA, P., Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int. J. Cancer, 69, 205-211 (1996).
8. GRANT, D.S., KIBBEY, M.C., KINSELLA, J.L., CID, M.C. and KLEINMAN, H.K., The role of basement membrane in angiogenesis and tumor growth. Pathol. Res. Pract., 190, 854-863 (1994).
9. HOLLINGSWORTH, H.C., KOHN, E.G., STEINBERG, S.M., ROTHENBERG, M.L. and MERINO, M.J., Tumor angiogenesis in advanced-stage ovarian carcinoma [see comments]. Amer. J. Pathol., 147, 33-41 (1995).
10. JERDAN, J.A., MICHELS, R.G. and GLASER, B.M., Extracellular matrix of newly forming vessels - an immunohistochemical study. Microvasc. Res., 42, 255-265 (1991).
11. KRISTENSEN, G.B. and TROPÉ, C., Epithelial ovarian carcinoma. Lancet, 349, 113-117 (1997).
12. KUWASHIMA, Y., UEHARA, T., KUROSUMI, M., KISHI, K., SHIROMIZU, K., MATSUZAWA, M. and TAKAYAMA, S., Basement-membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type-IV collagen and laminin. Europ. J. gynaecol. Oncol., 16, 181-186 (1995).
13. LEU, F.J. and DAMJANOV, I., Protease treatment combined with immunohistochemistry reveals heterogeneity of normal and neoplastic basement membranes. J. Histochem. Cytochem., 36, 213-220 (1988).
14. LIOTTA, L.A., STEEG, P.S. and STETLER-STEVENSON, W.G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
15. MARTINEZ-HERNANDEZ, A. and AMENTA, P.S., The basement membrane in pathology. Lab. Invest., 48, 656-677 (1983).
16. ORRE, M., LOTFI-MIRI, M., MAMERS, P. and ROGERS, P.A.W., Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary. Brit. J. Cancer, (1998). (In press).
17. PAULSSON, M., Basement-membrane proteins: structure, assembly, and cellular interactions. Crit. Rev. Biochem. mol. Biol., 27, 93-127 (1992).
18. RAK, J.W., ST CROIX, B.D. AND KERBEL, R.S., Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs, 6, 3-18 (1995).
19. SCHLINGEMANN, R.O., RIETVELD, F.J., KWASPEN, F., VAN DE KERKHOF, P.C., DE WAAL, R.M. and RUITER, D.J., Differential expression of markers for endothelial cells, pericytes and basal lamina in the microvasculature of tumors and granulation tissue. Amer. J. Pathol., 138, 1335-1347 (1991).
20. TIMPL, R., Proteoglycans of basement membranes. Experientia Suppl., 70, 123-144 (1994).
21. VISSCHER, D.W., LAWRENCE, W.D. and BOMAN, S., Angiogenesis in breast carcinoma-clinicopathologic relevance and potential use as a quantifiable surrogate endpoint biomarker. J. cell. Biochem. Suppl., 19, 146-152 (1994).
22. WEIDNER, N., Intratumor microvessel density as a prognostic factor in cancer (comment). Amer. J. Pathol., 147, 9-19 (1995).
23. WEIDNER, N., SEMPLE, J.P., WELCH, W.R. and FOLKMAN, J., Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New Engl. J. Med., 324, 1-8 (1991).